Integrated approach to Lipid-Based Formulations (LBF)
7:59
Integrated approach to Lipid-Based Formulations (LBF)
2 ай бұрын
Trends and Challenges in Pharmaceutical Development
9:39
Trends and Challenges in Pharmaceutical Development
4 ай бұрын
Developing and Manufacturing Highly Potent APIs
2:40
Developing and Manufacturing Highly Potent APIs
7 ай бұрын
Catalent 2023 Holiday Greeting Card
0:33
Catalent 2023 Holiday Greeting Card
8 ай бұрын
UpTempo℠ AAV Platform Process Accelerates Time From Gene To Clinic
2:25
UpTempo℠ AAV Platform Process Accelerates Time From Gene To Clinic
8 ай бұрын
Accelerating Clinical Supply Through Integrated Drug Development
4:36
Accelerating Clinical Supply Through Integrated Drug Development
11 ай бұрын
Pathways for Pulmonary Delivery
4:08
Pathways for Pulmonary Delivery
11 ай бұрын
Revolutionizing Drug Delivery With Innovative Softgel Technologies
5:07
Revolutionizing Drug Delivery With Innovative Softgel Technologies
11 ай бұрын
Specialized Support for Clinical Supplies
3:09
Specialized Support for Clinical Supplies
Жыл бұрын
Zydis® ODT - Effective Solutions for Sublingual Allergy Therapy
1:09
Zydis® ODT - Effective Solutions for Sublingual Allergy Therapy
Жыл бұрын
Zydis® ODT Unlocks Patient Preference for Rapid Onset in the Treatment of Migraine
1:15
Zydis® ODT Unlocks Patient Preference for Rapid Onset in the Treatment of Migraine
Жыл бұрын
Zydis® ODT as a Patient-Centric Drug Delivery Solution
8:24
Zydis® ODT as a Patient-Centric Drug Delivery Solution
Жыл бұрын
Webinar | How Natural Vegetarian Softgels Can Address Needs of the Natural Consumer
56:44
Webinar | How Natural Vegetarian Softgels Can Address Needs of the Natural Consumer
Жыл бұрын
Zydis® ODT Fast Dissolve Technology
3:03
Zydis® ODT Fast Dissolve Technology
Жыл бұрын
Catalent’s iPSCs as a Starting Material for Advanced Cell Therapies
1:44
Catalent’s iPSCs as a Starting Material for Advanced Cell Therapies
Жыл бұрын
GPEx® Lightning: The Latest Cell Line Development Technology
2:09
GPEx® Lightning: The Latest Cell Line Development Technology
Жыл бұрын
Catalent Cell & Gene Therapies - Changing the Healthcare Landscape
5:59
Catalent Cell & Gene Therapies - Changing the Healthcare Landscape
Жыл бұрын
mRNA - A New Option for Vaccines and Therapeutics
4:42
mRNA - A New Option for Vaccines and Therapeutics
Жыл бұрын
mRNA Development and Manufacturing - CMC Challenges and Solutions
7:26
mRNA Development and Manufacturing - CMC Challenges and Solutions
Жыл бұрын
The Unique Challenges of Lipid Nanoparticle Development and Manufacturing
6:31
The Unique Challenges of Lipid Nanoparticle Development and Manufacturing
Жыл бұрын
Choosing a CDMO Partner for Your Late-Stage and Commercial Biologics Programs
3:57
Choosing a CDMO Partner for Your Late-Stage and Commercial Biologics Programs
Жыл бұрын
Factors to Consider When Choosing a CDMO for Late-stage Biologics Programs
1:05
Factors to Consider When Choosing a CDMO for Late-stage Biologics Programs
Жыл бұрын
Challenges for mRNA LNP Formulation Development and Manufacturing
1:39
Challenges for mRNA LNP Formulation Development and Manufacturing
Жыл бұрын
What Are the Challenges Associated With in Vitro Transcription When Manufacturing mRNA?
1:49
What Are the Challenges Associated With in Vitro Transcription When Manufacturing mRNA?
Жыл бұрын
Technologies Addressing Stability & Delivery for mRNA Therapies/Vaccines
1:15
Technologies Addressing Stability & Delivery for mRNA Therapies/Vaccines
Жыл бұрын
What Are Some of the Unique Challenges Associated With mRNA Compared With Other Biologics?
2:06
What Are Some of the Unique Challenges Associated With mRNA Compared With Other Biologics?
Жыл бұрын
What Are Some of the Challenges Developing and Manufacturing Bi- and Multi-specific Antibodies?
2:06
What Are Some of the Challenges Developing and Manufacturing Bi- and Multi-specific Antibodies?
Жыл бұрын
Catalent Corporate Overview
3:46
Catalent Corporate Overview
Жыл бұрын
iPSCs, a Universal Starting Material for Cell Therapies
2:24
iPSCs, a Universal Starting Material for Cell Therapies
Жыл бұрын
Пікірлер